Document Detail

Survival determinants in black patients with angiographically defined coronary artery disease.
MedLine Citation:
PMID:  2137959     Owner:  NLM     Status:  MEDLINE    
Long-term survival of blacks with angiographically defined coronary artery disease was examined in a series of 1233 consecutive patients who underwent cardiac catheterization at a large urban municipal hospital. Vital status information was available at a mean of 86 weeks for the cohort as a whole, and 94 deaths were recorded. As noted in other angiographic series that included blacks, a high proportion of patients in this study had unobstructed coronary arteries (41%), and there was a preponderance of women (56%). Hypertension was present in 82% of the cases, whereas 68% of the sample had left ventricular hypertrophy as revealed by echocardiogram. The cumulative proportion of patients who were surviving at 5 years was 90 +/- 1 (+/- SEM), 79 +/- 4, and 70 +/- 4 for patients with no obstructive lesions, one-vessel disease, and multivessel disease, respectively. The survival rate at 3 years for patients who had undergone bypass surgery (N = 152) was only 82% (+/- 5%). Noninvasive univariate predictors of mortality included male sex, history of myocardial infarction, Q waves on electrocardiogram, exercise duration on treadmill stress testing, and left ventricular hypertrophy. Angiographic predictors included left ventricular end-diastolic pressure, the number of diseased coronary vessels, ejection fraction, and mean pulmonary artery pressure. Regression analysis showed an independent association for all the angiographic variables noted previously as well as for echocardiographically determined left ventricular hypertrophy. Survival rates for blacks with coronary artery disease in this series were considerably lower than those currently reported for whites, particularly for patients who underwent coronary bypass grafting.(ABSTRACT TRUNCATED AT 250 WORDS)
B E Simmons; A Castaner; M Mar; N Islam; R Cooper
Related Documents :
12204749 - Lipomatous interatrial septal hypertrophy: an unusual cause of intracardiac mass.
2485029 - Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium.
2137959 - Survival determinants in black patients with angiographically defined coronary artery d...
18995179 - Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left v...
20823719 - Cardiac hypertrophy and remodelling: pathophysiological consequences and protective eff...
1827059 - Dipyridamole echocardiography stress testing in hypertensive patients. targets and tools.
17703259 - Comparison of computed tomographic angiography versus rubidium-82 positron emission tom...
16055209 - Ontario score and cardiac risk during waiting for elective coronary bypass grafting.
23926119 - Effectiveness of percutaneous coronary intervention with drug-eluting stents compared w...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American heart journal     Volume:  119     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1990 Mar 
Date Detail:
Created Date:  1990-03-30     Completed Date:  1990-03-30     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  513-9     Citation Subset:  AIM; IM    
Department of Medicine, Morehouse School of Medicine, Atlanta, Ga.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
African Americans
African Continental Ancestry Group*
Cardiomegaly / epidemiology
Cohort Studies
Coronary Angiography
Coronary Disease / mortality*
Hypertension / epidemiology
Middle Aged
Regression Analysis
Risk Factors
Socioeconomic Factors
Survival Rate
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A suspected case of trimethoprim/sulfonamide-induced localized exfoliation.
Next Document:  Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study.